表紙
市場調査レポート

世界のポイントオブケア(PoC)診断市場:パイプライン分析、競争環境、2018年までの市場予測

Point-of-Care Diagnostics - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018

発行 GlobalData 商品コード 237527
出版日 ページ情報 英文 86 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.32円で換算しております。
Back to Top
世界のポイントオブケア(PoC)診断市場:パイプライン分析、競争環境、2018年までの市場予測 Point-of-Care Diagnostics - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018
出版日: 2012年04月12日 ページ情報: 英文 86 Pages
概要

当レポートでは、世界のポイントオブケア(Point-of-Care、以下PoC)関連市場について分析し、市場全体の構造や、全世界および主要7カ国の部門別の市場収益予測値(2012〜2018年)、主要企業のプロファイル、パイプライン製品、資本取引動向などの情報を盛り込んで、その結果を概略以下の構成でお届けします。

第1章 目次

第2章 イントロダクション

第3章 装置の概要

第4章 市場の特徴

  • PoC診断市場の収益総額予測値(全世界、2011〜2018年)
  • 臨床化学PoC診断市場の収益総額予測値(全世界、2011〜2018年)
  • 免疫化学PoC診断市場の収益総額予測値(全世界、2011〜2018年)
  • 血液PoC診断市場の収益総額予測値(全世界、2011〜2018年)
  • PoC診断市場の傾向
    • PoC検査の結果と電子カルテとの統合の推進
    • 体外診断におけるPoC検査結果の共有の増加傾向
    • PoC検査向けの分子診断の適用増加に対する期待
  • PoC診断市場のダイナミクス
    • 市場促進要因
    • 市場抑制要因

第5章 各国市場の予測(2011〜2018年)

  • PoC診断市場の収益総額予測値(米国、2011〜2018年)
  • 臨床化学PoC診断市場の収益総額予測値(米国、2011〜2018年)
  • 免疫化学PoC診断市場の収益総額予測値(米国、2011〜2018年)
  • 血液PoC診断市場の収益総額予測値(米国、2011〜2018年)
  • PoC診断市場の収益総額予測値(カナダ、2011〜2018年)
  • 臨床化学PoC診断市場の収益総額予測値(カナダ、2011〜2018年)
  • 免疫化学PoC診断市場の収益総額予測値(カナダ、2011〜2018年)
  • 血液PoC診断市場の収益総額予測値(カナダ、2011〜2018年)
  • PoC診断市場の収益総額予測値(英国、2011〜2018年)
  • 臨床化学PoC診断市場の収益総額予測値(英国、2011〜2018年)
  • 免疫化学PoC診断市場の収益総額予測値(英国、2011〜2018年)
  • 血液PoC診断市場の収益総額予測値(英国、2011〜2018年)
  • PoC診断市場の収益総額予測値(ドイツ、2011〜2018年)
  • 臨床化学PoC診断市場の収益総額予測値(ドイツ、2011〜2018年)
  • 免疫化学PoC診断市場の収益総額予測値(ドイツ、2011〜2018年)
  • 血液PoC診断市場の収益総額予測値(ドイツ、2011〜2018年)
  • PoC診断市場の収益総額予測値(フランス、2011〜2018年)
  • 臨床化学PoC診断市場の収益総額予測値(フランス、2011〜2018年)
  • 免疫化学PoC診断市場の収益総額予測値(フランス、2011〜2018年)
  • 血液PoC診断市場の収益総額予測値(フランス、2011〜2018年)
  • PoC診断市場の収益総額予測値(イタリア、2011〜2018年)
  • 臨床化学PoC診断市場の収益総額予測値(イタリア、2011〜2018年)
  • 免疫化学PoC診断市場の収益総額予測値(イタリア、2011〜2018年)
  • 血液PoC診断市場の収益総額予測値(イタリア、2011〜2018年)
  • PoC診断市場の収益総額予測値(スペイン、2011〜2018年)
  • 臨床化学PoC診断市場の収益総額予測値(スペイン、2011〜2018年)
  • 免疫化学PoC診断市場の収益総額予測値(スペイン、2011〜2018年)
  • 血液PoC診断市場の収益総額予測値(スペイン、2011〜2018年)
  • PoC診断市場の収益総額予測値(日本、2011〜2018年)
  • 臨床化学PoC診断市場の収益総額予測値(日本、2011〜2018年)
  • 免疫化学PoC診断市場の収益総額予測値(日本、2011〜2018年)
  • 血液PoC診断市場の収益総額予測値(日本、2011〜2018年)

第6章 戦略的競合企業評価

  • 主要企業のシェア(全世界、2011年)
  • 市場機会とリスクの評価
    • 市場機会の評価
    • リスクの評価
  • 主な市場参加企業
    • Alere, Inc
    • La Hoffmann Roche, Inc
    • Siemens Healthcare Diagnostics
    • Abbott Laboratories

第7章 戦略的パイプライン評価

  • 製品パイプライン分析
  • パイプライン製品の一覧
  • 臨床開発段階にある主要製品のプロファイル
    • Cerebrostrip Diagnostic Test
    • Osmo POC Dehydration Diagnostic System
    • WOUNDCHEK Protease Status
    • Preterm Birth Prediction Test
    • Point-of-Care Rapid Portable Biosensor
    • Point-of-Care Testing Device
    • POC Screening Device - Dyssynergic Defecation
    • Point-Of-Care Dipstick Test - Acetaminophen-Induced Liver Injury

第8章 主な企業合併・買収(2011年)

  • Modern Mobility AidsによるLumiGene Technologiesの買収完了
    • 概要
    • 取引の理論的根拠
  • Opko HealthによるClaros Diagnosticsの買収
    • 概要
    • 取引の理論的根拠
  • SonyによるMicronicsの買収
    • 概要
    • 取引の理論的根拠
  • EKF Diagnosticsによる、Stanbio Laboratoryの買収完了
    • 概要
    • 取引の理論的根拠
  • CerMed InternationalによるViridis Bioscienceの買収
    • 概要
    • 取引の理論的根拠

第9章 付録

図表一覧

目次
Product Code: GDME0147MAR

Summary

GlobalData's new report, "Point-of-Care Diagnostics - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018" provides key data, information and analysis on the global Point of Care (POC) diagnostics market. The report provides market landscape, competitive landscape and market trends information on the POC diagnostics market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

  • Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, and Japan.
  • Key segments covered include Clinical Chemistry, Immuno Chemistry and Hematology.
  • Annualized market revenues data from forecast forward for seven years to 2018. Company shares data for 2011.
  • Qualitative analysis of key market trends, market drivers, and restraints within point of care diagnostics market.
  • The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
  • Key players covered include F. Hoffmann-La Roche Ltd., Alere, Inc., Siemens Healthcare and Abbott Laboratories.

Reasons to buy

  • Develop business strategies by understanding the trends and developments that are driving the POC diagnostics market globally.
  • Design and develop your product development, marketing and sales strategies.
  • Develop market-entry and market expansion strategies.
  • Identify key players best positioned to take advantage of the emerging market opportunities.
  • Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return.
  • What's the next big thing in the POC diagnostics market landscape? - Identify, understand and capitalize.
  • Make more informed business decisions from the insightful and in-depth analysis of the global POC diagnostics market and the factors shaping it.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Point-of-Care Diagnostics - Introduction

  • 2.1. GlobalData Report Guidance

3. Device Overview - Point-of-Care Diagnostics

4. PoC Diagnostics - Market Characterization

  • 4.1. Point-of-Care Diagnostics Market, Global, Revenue ($m), Forecast, 2011-2018
  • 4.2. Clinical Chemistry Point-of-Care Diagnostics Market, Global, Revenue ($m), Forecast, 2011-2018
  • 4.3. Immunochemistry Point-of-Care Diagnostics Market, Global, Revenue ($m), Forecast, 2011-2018
  • 4.4. Hematology Point-of-Care Diagnostics Market, Global, Revenue ($m), Forecast, 2011-2018
  • 4.5. PoC Diagnostics, Market Trends
    • 4.5.1. Integration of Results from Point-of-Care Testing with Electronic Medical Records on the Rise
    • 4.5.2. Trend towards Increase in the Share of Point-of-Care Testing Within In Vitro Diagnostics
    • 4.5.3. Growth in the Adoption of Molecular Diagnostics for Point-of-Care Testing is Expected
  • 4.6. PoC Diagnostics, Market Dynamics
    • 4.6.1. Market Drivers
    • 4.6.2. Market Restraints

5. Point-of-Care Diagnostics Market, by Country, Revenue ($m), 2011-2018

  • 5.1. Point-of-Care Diagnostics Market, The US, Revenue ($m), Forecast, 2011-2018
  • 5.2. Clinical Chemistry PoC Diagnostics Market, The US, Revenue ($m), Forecast, 2011-2018
  • 5.3. Immunochemistry PoC Diagnostics Market, The US, Revenue ($m), Forecast, 2011-2018
  • 5.4. Hematology PoC Diagnostics Market, The US, Revenue ($m), Forecast, 2011-2018
  • 5.5. Point-of-Care Diagnostics Market, Canada, Revenue ($m), Forecast, 2011-2018
  • 5.6. Clinical Chemistry PoC Diagnostics Market, Canada, Revenue ($m), Forecast, 2011-2018
  • 5.7. Immunochemistry PoC Diagnostics Market, Canada, Revenue ($m), Forecast, 2011-2018
  • 5.8. Hematology PoC Diagnostics Market, Canada, Revenue ($m), Forecast, 2011-2018
  • 5.9. Point-of-Care Diagnostics Market, The UK, Revenue ($m), Forecast, 2011-2018
  • 5.10. Clinical Chemistry PoC Diagnostics Market, The UK, Revenue ($m), Forecast, 2011-2018
  • 5.11. Immunochemistry PoC Diagnostics Market, The UK, Revenue ($m), Forecast, 2011-2018
  • 5.12. Hematology PoC Diagnostics Market, The UK, Revenue ($m), Forecast, 2011-2018
  • 5.13. Point-of-Care Diagnostics Market, Germany, Revenue ($m), Forecast, 2011-2018
  • 5.14. Clinical Chemistry PoC Diagnostics Market, Germany, Revenue ($m), Forecast, 2011-2018
  • 5.15. Immunochemistry PoC Diagnostics Market, Germany, Revenue ($m), Forecast, 2011-2018
  • 5.16. Hematology PoC Diagnostics Market, Germany, Revenue ($m), Forecast, 2011-2018
  • 5.17. Point-of-Care Diagnostics Market, France, Revenue ($m), Forecast, 2011-2018
  • 5.18. Clinical Chemistry PoC Diagnostics Market, France, Revenue ($m), Forecast, 2011-2018
  • 5.19. Immunochemistry PoC Diagnostics Market, France, Revenue ($m), Forecast, 2011-2018
  • 5.20. Hematology PoC Diagnostics Market, France, Revenue ($m), Forecast, 2011-2018
  • 5.21. Point-of-Care Diagnostics Market, Italy, Revenue ($m), Forecast, 2011-2018
  • 5.22. Clinical Chemistry PoC Diagnostics Market, Italy, Revenue ($m), Forecast, 2011-2018
  • 5.23. Immunochemistry PoC Diagnostics Market, Italy, Revenue ($m), Forecast, 2011-2018
  • 5.24. Hematology PoC Diagnostics Market, Italy, Revenue ($m), Forecast, 2011-2018
  • 5.25. Point-of-Care Diagnostics Market, Spain, Revenue ($m), Forecast, 2011-2018
  • 5.26. Clinical Chemistry PoC Diagnostics Market, Spain, Revenue ($m), Forecast, 2011-2018
  • 5.27. Immunochemistry PoC Diagnostics Market, Spain, Revenue ($m), Forecast, 2011-2018
  • 5.28. Hematology PoC Diagnostics Market, Spain, Revenue ($m), Forecast, 2011-2018
  • 5.29. Point-of-Care Diagnostics Market, Japan, Revenue ($m), Forecast, 2011-2018
  • 5.30. Clinical Chemistry PoC Diagnostics Market, Japan, Revenue ($m), Forecast, 2011-2018
  • 5.31. Immunochemistry PoC Diagnostics Market, Japan, Revenue ($m), Forecast, 2011-2018
  • 5.32. Hematology PoC Diagnostics Market, Japan, Revenue ($m), Forecast, 2011-2018

6. Point-of-Care Diagnostics Market - Strategic Competitive Assessment

  • 6.1. Point-of-Care Diagnostics Market, Global, Key Company Share (%), 2011
  • 6.2. PoC Diagnostics, Market Opportunities and Risk Evaluation
    • 6.2.1. Opportunities Assessment
    • 6.2.2. Risk Evaluation
  • 6.3. PoC Diagnostics, Key Market Participants
    • 6.3.1. Alere, Inc
    • 6.3.2. La Hoffmann Roche, Inc.
    • 6.3.3. Siemens Healthcare Diagnostics
    • 6.3.4. Abbott Laboratories

7. Point-of-Care Diagnostics Market - Strategic Pipeline Assessment

  • 7.1. PoC Diagnostics: Product Pipeline Analysis
  • 7.2. PoC Diagnostics, List of Pipeline Products
  • 7.3. PoC Diagnostics: Profiles of Key Products under Clinical Development
    • 7.3.1. Cerebrostrip Diagnostic Test
    • 7.3.2. Osmo POC Dehydration Diagnostic System
    • 7.3.3. WOUNDCHEK Protease Status
    • 7.3.4. Preterm Birth Prediction Test
    • 7.3.5. Point-of-Care Rapid Portable Biosensor
    • 7.3.6. Point-of-Care Testing Device
    • 7.3.7. POC Screening Device - Dyssynergic Defecation
    • 7.3.8. Point-Of-Care Dipstick Test - Acetaminophen-Induced Liver Injury

8. Point-of-Care Diagnostics Market - Key Mergers and Acquisitions (2011)

  • 8.1. Modern Mobility Aids Finalizes Acquisition of LumiGene Technologies
    • 8.1.1. Overview
    • 8.1.2. Deal Rationale
  • 8.2. Opko Health Acquires Claros Diagnostics
    • 8.2.1. Overview
    • 8.2.2. Deal Rationale
  • 8.3. Sony Acquires Micronics
    • 8.3.1. Overview
    • 8.3.2. Deal Rationale
  • 8.4. EKF Diagnostics Completes Acquisition of Stanbio Laboratory
    • 8.4.1. Overview
    • 8.4.2. Deal Rationale
  • 8.5. CerMed International Acquires Viridis Bioscience
    • 8.5.1. Overview
    • 8.5.2. Deal Rationale

9. Appendix

  • 9.1. Definitions
    • 9.1.1. PoC Diagnostics
  • 9.2. Acronyms
  • 9.3. Sources
  • 9.4. Research Methodology
  • 9.5. Secondary Research
  • 9.6. Primary Research
  • 9.7. Models
  • 9.8. Forecasts
  • 9.9. Expert Panels
  • 9.10. GlobalData Consulting
  • 9.11. Contact Us
  • 9.12. Disclaimer

List of Tables

  • Table 1: Point-of-Care Diagnostics Market, Global, Revenue ($m), 2011-2018
  • Table 2: Clinical Chemistry Point-of-Care Diagnostics Market, Global, Revenue ($m), 2011-2018
  • Table 3: Immunochemistry Point-of-Care Diagnostics Market, Global, Revenue ($m), 2011-2018
  • Table 4: Hematology Point-of-Care Diagnostics Market, Global, Revenue ($m), 2011-2018
  • Table 5: Electronic Medical Records Market, Global, Revenue ($bn), Forecast, 2011-2018
  • Table 6: Percentage Adoption of Point-of-Care Testing and Centralized Laboratory Testing, Global, 2011-2018
  • Table 7: Molecular Diagnostics Market, Global, Revenue ($bn), Forecast, 2011-2015
  • Table 8: Vacancy Rates by Department in Clinical Laboratories, The US, 2011
  • Table 9: New Product Launches, 2011
  • Table 10: Percentage of People Aged 65 Years and Above in the Total Adult Population, by Country, %, 1980-2050
  • Table 11: Point-of-Care Diagnostics Market, The US, Revenue ($m), 2011-2018
  • Table 12: Clinical Chemistry PoC Diagnostics Market, The US, Revenue ($m), 2011-2018
  • Table 13: Immunochemistry PoC Diagnostics Market, The US, Revenue ($m), 2011-2018
  • Table 14: Hematology PoC Diagnostics Market, The US, Revenue ($m), 2011-2018
  • Table 15: Point-of-Care Diagnostics Market, Canada, Revenue ($m), 2011-2018
  • Table 16: Clinical Chemistry PoC Diagnostics Market, Canada, Revenue ($m), 2011-2018
  • Table 17: Immunochemistry PoC Diagnostics Market, Canada, Revenue ($m), 2011-2018
  • Table 18: Hematology PoC Diagnostics Market, Canada, Revenue ($m), 2011-2018
  • Table 19: Point-of-Care Diagnostics Market, The UK, Revenue ($m), 2011-2018
  • Table 20: Clinical Chemistry PoC Diagnostics Market, The UK, Revenue ($m), 2011-2018
  • Table 21: Immunochemistry PoC Diagnostics Market, The UK, Revenue ($m), 2011-2018
  • Table 22: Hematology PoC Diagnostics Market, The UK, Revenue ($m), 2011-2018
  • Table 23: Point-of-Care Diagnostics Market, Germany, Revenue ($m), 2011-2018
  • Table 24: Clinical Chemistry PoC Diagnostics Market, Germany, Revenue ($m), 2011-2018
  • Table 25: Immunochemistry PoC Diagnostics Market, Germany, Revenue ($m), 2011-2018
  • Table 26: Hematology PoC Diagnostics Market, Germany, Revenue ($m), 2011-2018
  • Table 27: Point-of-Care Diagnostics Market, France, Revenue ($m), 2011-2018
  • Table 28: Clinical Chemistry PoC Diagnostics Market, France, Revenue ($m), 2011-2018
  • Table 29: Immunochemistry PoC Diagnostics Market, France, Revenue ($m), 2011-2018
  • Table 30: Hematology PoC Diagnostics Market, France, Revenue ($m), 2011-2018
  • Table 31: Point-of-Care Diagnostics Market, Italy, Revenue ($m), 2011-2018
  • Table 32: Clinical Chemistry PoC Diagnostics Market, Italy, Revenue ($m), 2011-2018
  • Table 33: Immunochemistry PoC Diagnostics Market, Italy, Revenue ($m), 2011-2018
  • Table 34: Hematology PoC Diagnostics Market, Italy, Revenue ($m), 2011-2018
  • Table 35: Point-of-Care Diagnostics Market, Spain, Revenue ($m), 2011-2018
  • Table 36: Clinical Chemistry PoC Diagnostics Market, Spain, Revenue ($m), 2011-2018
  • Table 37: Immunochemistry PoC Diagnostics Market, Spain, Revenue ($m), 2011-2018
  • Table 38: Hematology PoC Diagnostics Market, Spain, Revenue ($m), 2011-2018
  • Table 39: Point-of-Care Diagnostics Market, Japan, Revenue ($m), 2011-2018
  • Table 40: Clinical Chemistry PoC Diagnostics Market, Japan, Revenue ($m), 2011-2018
  • Table 41: Immunochemistry PoC Diagnostics Market, Japan, Revenue ($m), 2011-2018
  • Table 42: Hematology PoC Diagnostics Market, Japan, Revenue ($m), 2011-2018
  • Table 43: Point-of-Care Diagnostics Market, Global, Key Company Revenue ($m), 2011
  • Table 44: Alere, Point-of-Care Diagnostics, Key Marketed Products
  • Table 45: Examples of Companies Acquired by Alere
  • Table 46: Roche, PoC Diagnostics, Key Marketed Products
  • Table 47: Siemens Healthcare, Point-of-Care Testing, Key Marketed Products
  • Table 48: Abbott Diagnostics, PoC Diagnostics, Key Marketed Products
  • Table 49: Pipeline Technology Assessment for PoC Diagnostics, Global, I
  • Table 50: Pipeline Technology Assessment for PoC Diagnostics, Global, II
  • Table 51: Cerebrostrip Diagnostic Test, Product Status
  • Table 52: Osmo POC Dehydration Diagnostic System, Product Status
  • Table 53: WOUNDCHEK Protease Status, Product Status
  • Table 54: Preterm Birth Prediction Test, Product Status
  • Table 55: Point-of-Care Rapid Portable Biosensor, Product Status
  • Table 56: Point-of-Care Testing Device, Product Status
  • Table 57: POC Screening Device - Dyssynergic Defecation, Product Status
  • Table 58: Point-Of-Care Dipstick Test - Acetaminophen-Induced Liver Injury, Product Status

List of Figures

  • Figure 1: Point-of-Care Diagnostics, Market Segmentation
  • Figure 2: Point-of-Care Diagnostics Market, Global, Revenue ($m), 2011-2018
  • Figure 3: Clinical Chemistry Point-of-Care Diagnostics Market, Global, Revenue ($m), 2011-2018
  • Figure 4: Immunochemistry Point-of-Care Diagnostics Market, Global, Revenue ($m), 2011-2018
  • Figure 5: Hematology Point-of-Care Diagnostics Market, Global, Revenue ($m), 2011-2018
  • Figure 6: Electronic Medical Records Market, Global, Revenue ($bn), Forecast, 2011-2018
  • Figure 7: Percentage Adoption of Point-of-Care Testing and Centralized Laboratory Testing, Global, 2011-2018
  • Figure 8: Molecular Diagnostics Market, Global, Revenue ($bn), Forecast, 2011-2015
  • Figure 9: Vacancy Rates by Department in Clinical Laboratories, The US, 2011
  • Figure 10: Percentage of People Aged 65 Years and Above in the Total Adult Population, by Country, %, 1980-2050
  • Figure 11: Point-of-Care Diagnostics Market, The US, Revenue ($m), 2011-2018
  • Figure 12: Clinical Chemistry PoC Diagnostics Market, The US, Revenue ($m), 2011-2018
  • Figure 13: Immunochemistry PoC Diagnostics Market, The US, Revenue ($m), 2011-2018
  • Figure 14: Hematology PoC Diagnostics Market, The US, Revenue ($m), 2011-2018
  • Figure 15: Point-of-Care Diagnostics Market, Canada, Revenue ($m), 2011-2018
  • Figure 16: Clinical Chemistry PoC Diagnostics Market, Canada, Revenue ($m), 2011-2018
  • Figure 17: Immunochemistry PoC Diagnostics Market, Canada, Revenue ($m), 2011-2018
  • Figure 18: Hematology PoC Diagnostics Market, Canada, Revenue ($m), 2011-2018
  • Figure 19: Point-of-Care Diagnostics Market, The UK, Revenue ($m), 2011-2018
  • Figure 20: Clinical Chemistry PoC Diagnostics Market, The UK, Revenue ($m), 2011-2018
  • Figure 21: Immunochemistry PoC Diagnostics Market, The UK, Revenue ($m), 2011-2018
  • Figure 22: Hematology PoC Diagnostics Market, The UK, Revenue ($m), 2011-2018
  • Figure 23: Point-of-Care Diagnostics Market, Germany, Revenue ($m), 2011-2018
  • Figure 24: Clinical Chemistry PoC Diagnostics Market, Germany, Revenue ($m), 2011-2018
  • Figure 25: Immunochemistry PoC Diagnostics Market, Germany, Revenue ($m), 2011-2018
  • Figure 26: Hematology PoC Diagnostics Market, Germany, Revenue ($m), 2011-2018
  • Figure 27: Point-of-Care Diagnostics Market, France, Revenue ($m), 2011-2018
  • Figure 28: Clinical Chemistry PoC Diagnostics Market, France, Revenue ($m), 2011-2018
  • Figure 29: Immunochemistry PoC Diagnostics Market, France, Revenue ($m), 2011-2018
  • Figure 30: Hematology PoC Diagnostics Market, France, Revenue ($m), 2011-2018
  • Figure 31: Point-of-Care Diagnostics Market, Italy, Revenue ($m), 2011-2018
  • Figure 32: Clinical Chemistry PoC Diagnostics Market, Italy, Revenue ($m), 2011-2018
  • Figure 33: Immunochemistry PoC Diagnostics Market, Italy, Revenue ($m), 2011-2018
  • Figure 34: Hematology PoC Diagnostics Market, Italy, Revenue ($m), 2011-2018
  • Figure 35: Point-of-Care Diagnostics Market, Spain, Revenue ($m), 2011-2018
  • Figure 36: Clinical Chemistry PoC Diagnostics Market, Spain, Revenue ($m), 2011-2018
  • Figure 37: Immunochemistry PoC Diagnostics Market, Spain, Revenue ($m), 2011-2018
  • Figure 38: Hematology PoC Diagnostics Market, Spain, Revenue ($m), 2011-2018
  • Figure 39: Point-of-Care Diagnostics Market, Japan, Revenue ($m), 2011-2018
  • Figure 40: Clinical Chemistry PoC Diagnostics Market, Japan, Revenue ($m), 2011-2018
  • Figure 41: Immunochemistry PoC Diagnostics Market, Japan, Revenue ($m), 2011-2018
  • Figure 42: Hematology PoC Diagnostics Market, Japan, Revenue ($m), 2011-2018
  • Figure 43: Point-of-Care Diagnostics Market, Global, Key Company Share (%), 2011
  • Figure 44: Point-of-Care Diagnostics, Market Opportunities and Risk Evaluation
  • Figure 45: Alere, Internal Factors Evaluation
  • Figure 46: Roche, Internal Factors Evaluation
  • Figure 47: Siemens Healthcare Diagnostics, Internal Factors Evaluation
  • Figure 48: Abbott Diagnostics, Internal Factors Evaluation
  • Figure 49: Pipeline Technology Assessment for PoC Diagnostics, Global, by Development Stage
Back to Top